General Overview
This proposal seeks to understand the role of ATRX/DAXX/H3.3-mediated chromatin dysregulation in pancreatic neuroendocrine tumors. These studies will identify important mechanisms of genome regulation, potentially transforming our understanding of neuroendocrine tumors with a goal towards the development of new diagnostic markers and possible new methods of intervention.